Savushkin / iStockphoto.com
Purdue Pharma has sued Collegium Pharmaceutical, in the latest development in a continuing patent infringement dispute centring on Purdue’s painkiller drug OxyContin (oxycodone).
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Purdue, Collegium; patent; patent infringement; NDA; New Drug Application; US District Court for the District of Massachusetts; Xtampza; OxyContin; oxycod